In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting.
暂无分享,去创建一个
S. Jurisson | T. Quinn | T P Quinn | M. Giblin | J Chen | S S Jurisson | M F Giblin | N Wang | J. Chen | N. Wang
[1] S. Strand,et al. Extracorporeal immunoadsorption compared to avidin chase: enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] M. Rajopadhye,et al. Labeling cyclic glycoprotein IIb/IIIa receptor antagonists with 99mTc by the preformed chelate approach: effects of chelators on properties of [99mTc]chelator-peptide conjugates. , 1996, Bioconjugate chemistry.
[3] D. Buchsbaum,et al. A peptide‐based bifunctional chelating agent for 99mtc‐ and 186re‐labeling of monoclonal antibodies , 1994, Cancer.
[4] V. Hruby,et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[5] V. Hruby,et al. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. , 1989, Journal of medicinal chemistry.
[6] W. Vale,et al. Bombesin:potent effects on thermoregulation in the rat. , 1977, Science.
[7] D. Wilbur,et al. Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. Gispen,et al. Pharmacological evidence for the involvement of endogenous α-MSH-like peptides in peripheral nerve regeneration , 1995, Peptides.
[9] T. Maughan,et al. The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma. , 1992, The British journal of radiology.
[10] S. Strand,et al. Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] J. Fitzner,et al. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] V. Hruby,et al. Melanotropic peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Eberle,et al. [111In]‐DTPA‐labeled analogues of α‐melanocyte‐stimulating hormone for melanoma targeting: Receptor binding in vitro and in vivo , 1994, International journal of cancer.
[14] K. Foon,et al. Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice. , 1990, Cancer research.
[15] V. Hruby,et al. Cyclic melanotropins. 9. 7-D-Phenylalanine analogues of the active-site sequence. , 1985, Journal of medicinal chemistry.
[16] Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate. , 1996 .
[17] C. Pouton,et al. Synthesis and biological evaluation of α-MSH analogues substituted with alanine , 1994, Peptides.
[18] M. Mortrud,et al. Cloning and Functional Characterization of a Family of Receptors for the Melanotropic Peptides , 1993, Annals of the New York Academy of Sciences.
[19] A. Eberle,et al. RADIORECEPTOR ASSAY FOR a-MSH USING MOUSE 816 MELANOMA CELLS+ , 1988 .
[20] S. Vallabhajosula,et al. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] S. Jurisson,et al. Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] G. Bormans,et al. Complexes of technetium-99m with tetrapeptides, a new class of 99mTc-labelled agents. , 1995, Nuclear medicine and biology.
[23] M. Zalutsky,et al. Fluorine-18-labeled [Nle4,d-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue , 1997 .
[24] C. G. Knight,et al. A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma. , 1990, British Journal of Cancer.
[25] J. Vanderheyden,et al. Comparisons of the efficacy of 186Re- and 131I-labeled antibody in multicell spheroids. , 1992, International journal of radiation oncology, biology, physics.
[26] S. Jurisson,et al. Synthesis and characterization of rhenium-complexed alpha-melanotropin analogs. , 1997, Bioconjugate chemistry.
[27] V. Hruby,et al. Design, Synthesis, and Conformation of Superpotent and Prolonged Acting Melanotropins a , 1993, Annals of the New York Academy of Sciences.
[28] G. Griffiths,et al. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. , 1991, Cancer research.
[29] R. Cone,et al. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. , 1995, Journal of medicinal chemistry.
[30] V. Hruby,et al. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. , 1997, Journal of medicinal chemistry.
[31] A. Eberle,et al. Characterization of Receptors for α-Melanocyte-stimulating Hormone on Human Melanoma Cells , 1989 .
[32] L L Houston,et al. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.